Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

Clonal Hematopoiesis: Cell of Origin, Lineage Repartition and Dynamic Evolution during Chemotherapy

Blood (2017) 130 (Supplement 1): 632.

https://doi.org/10.1182/blood.V130.Suppl_1.632.632

Published: 2017

Journal Articles

Prognostic Impact of Distinct Combinations of Molecular Mutations in AML Patients. Results of Two-Center International Cooperation Study

Olga Blau, MD PhD, Irina Martynkevich, MD PhD, Franziska Behrenbeck, Claudia D. Baldus, MD, Ekaterina Motiko, Sergei Voloshin, MD PhD, Antonio Pezzutto, MD PhD, Bernd Dorken, MD PhD, Igor Wolfgang Blau, MD PhD

Blood (2017) 130 (Supplement 1): 5111.

https://doi.org/10.1182/blood.V130.Suppl_1.5111.5111

Published: 2017

Journal Articles

Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma

Blood (2017) 129 (1): 71–81.

https://doi.org/10.1182/blood-2016-02-700773

Published: 2017

Includes: Supplemental data

Journal Articles

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

Larry Mansouri, Daniel Noerenberg, Emma Young, Elena Mylonas, Maysaa Abdulla, Mareike Frick, Fazila Asmar, Viktor Ljungström, Markus Schneider, Kenichi Yoshida, Aron Skaftason, Tatjana Pandzic, Blanca Gonzalez, Anna Tasidou, Nils Waldhueter, Alfredo Rivas-Delgado, Maria Angelopoulou, Marita Ziepert, Christopher Maximilian Arends, Lucile Couronné, Dido Lenze, Claudia D. Baldus, Christian Bastard, Jessica Okosun, Jude Fitzgibbon, Bernd Dörken, Hans G. Drexler, Damien Roos-Weil, Clemens A. Schmitt, Helga D. Munch-Petersen, Thorsten Zenz, Martin-Leo Hansmann, Jonathan C. Strefford, Gunilla Enblad, Olivier A. Bernard, Elisabeth Ralfkiaer, Martin Erlanson, Penelope Korkolopoulou, Magnus Hultdin, Theodora Papadaki, Kirsten Grønbæk, Armando Lopez-Guillermo, Seishi Ogawa, Ralf Küppers, Kostas Stamatopoulos, Niki Stavroyianni, George Kanellis, Andreas Rosenwald, Elias Campo, Rose-Marie Amini, German Ott, Theodoros P. Vassilakopoulos, Michael Hummel, Richard Rosenquist, Frederik Damm

Blood (2016) 128 (23): 2666–2670.

https://doi.org/10.1182/blood-2016-03-704528

Published: 2016

Includes: Supplemental data

Journal Articles

DNMT3A Mutations in AML Patients: Prognostic Impact and Comparative Analysis of Mutations Burden in Diagnostic Samples, after Standard Therapy, and after Allogeneic Stem Cell Transplantation

Olga Blau, MD PhD, Franziska Behrenbeck, Nikola Suckert, Lars R. Fransecky, MD, Claudia D. Baldus, MD, Renate Arnold, MD PhD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Igor Wolfgang Blau, MD PhD

Blood (2016) 128 (22): 2891.

https://doi.org/10.1182/blood.V128.22.2891.2891

Published: 2016

Journal Articles

ΝFΚΒΙΕ Deletions : A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma

Daniel Noerenberg*, Larry Mansouri*, Emma Young, Frick Mareike, Maysaa Abdulla, Fazila Asmar, Blanca Gonzalez-Farre, Tasidou Anna, Nils Waldhueter, Viktor Ljungström, Alfredo Rivas, Maria K. Angelopoulou, Marita Ziepert, Christopher M. Arends, Lucile Couronne, Dido Lenze, Claudia D. Baldus, MD, Christian Bastard, Jessica Okosun, Jude Fitzgibbon, Bernd Dörken, Hans G. Drexler, Damien Roos-Weil, Clemens A. Schmitt, Helga Duverger Munch-Petersen, Thorsten Zenz, Jonathan C. Strefford, Gunilla Enblad, Olivier A. Bernard, Elisabeth Ralfkiaer, Penelope Korkolopoulou, Magnus Hultdin, Theodora Papadaki, Kirsten Grønbæk, Armando Lopez-Guillermo, Kostas Stamatopoulos, MD PhD, Niki Stavroyianni, George Kanellis, Andreas Rosenwald, MD, Elias Campo, Rose-Marie Amini, German Ott, Theodoros Vassilakopoulos, Michael Hummel, Frederik Damm**, Richard Rosenquist**

Blood (2016) 128 (22): 609.

https://doi.org/10.1182/blood.V128.22.609.609

Published: 2016

Journal Articles

Restoring the Lost B-Cell Phenotype Renders Classical Hodgkin's Lymphoma Susceptible to B-Cell-Targeting Therapies

Nina Rosa Neuendorff, MD, Jing Du, PhD, Yong Yu, PhD, Jens Peter von Kries, PhD, Stephan Mathas, MD, Bernd Dörken, Prof., Soyoung Lee, PhD, Clemens A. Schmitt, MD Prof

Blood (2016) 128 (22): 1094.

https://doi.org/10.1182/blood.V128.22.1094.1094

Published: 2016

Journal Articles

A Novel Bioluminescent Mouse Model for Optimization of Adoptive T Cell Therapy

Martin Szyska, PhD, Stefanie Herda, PhD, Stefanie Althoff, Andreas Heimann, Tra My Dang, Bernd Dörken, MD PhD, Thomas Blankenstein, Il-Kang Na, MD

Blood (2016) 128 (22): 2162.

https://doi.org/10.1182/blood.V128.22.2162.2162

Published: 2016

Journal Articles

Efficacy of Adoptive Immunotherapy By Donor Lymphocyte Infusions after Allogeneic Stem Cell Transplantation from Related an Unrelated Donors: A Single Center Retrospective Analysis

Philipp Hemmati, MD, Christin Vogelsänger, Theis Terwey, MD, Christian Jehn, MD, Lam G. Vuong, MD PhD, Igor Wolfgang Blau, MD, Olaf Penack, MD, Bernd Dörken, Renate Arnold, MD PhD

Blood (2016) 128 (22): 4556.

https://doi.org/10.1182/blood.V128.22.4556.4556

Published: 2016

Journal Articles

Droplet Digital PCR Reliably Detects a Single Copy of BCR-ABL1

Jaspal Kaeda, PhD FRCPath, Simone Bonecker, Frauke Ringel, Michaela Schwarz, Bernd Dörken, Ilana Zalcberg, Philipp Le Coutre, MD

Blood (2015) 126 (23): 2784.

https://doi.org/10.1182/blood.V126.23.2784.2784

Published: 2015

Journal Articles

Modeling the CNS Tropism of Diffuse Large B-Cell Lymphomas in Vivo

Maurice Reimann, Dr., Sven Masswig, Kolja Schleich, Dr., Andrea Herrmann, Philipp Lohneis, MD, Jens Schrezenmeier, Bernd Dörken, Prof., Clemens Schmitt

Blood (2015) 126 (23): 576.

https://doi.org/10.1182/blood.V126.23.576.576

Published: 2015

Journal Articles

Grouping of Genetic Risk By the European Leukemia Net Classification Predicts Overall Survival and Relapse Incidence in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Philipp G. Hemmati, MD, Theis Terwey, MD, Il-Kang Na, MD, Christian Jehn, MD, Lam G. Vuong, PhD, Philipp le Coutre, MD, Bernd Dörken, MD, Renate Arnold, MD

Blood (2015) 126 (23): 2012.

https://doi.org/10.1182/blood.V126.23.2012.2012

Published: 2015

Journal Articles

Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma

Blood (2015) 125 (1): 124–132.

https://doi.org/10.1182/blood-2014-08-594507

Published: 2015

Includes: Supplemental data

Journal Articles

Frequency of a Highly Polymorphic Variant, S36N GFI1 , Is Increased in CML Patients

Jaspal S Kaeda, PhD, Leila Amini, BSc, Concetta Quintarelli, PhD, Iris von Wunsch-Rolshoven, Frauke Ringel, PhD, Michaela Schwarz, MD, Fabrizio Pane, MD, Bernd Dörken, MD, Philipp le Coutre, MD

Blood (2014) 124 (21): 3157.

https://doi.org/10.1182/blood.V124.21.3157.3157

Published: 2014

Journal Articles

Multiple Myeloma Cells Induce Mitochondrial Stress Response in Bone Marrow Mesenchymal Stromal Cells

Rimma Berenstein, Olga Blau, MD PhD, Axel Nogai, MD, Marlies Wächter, Martin Schmidt-Hieber, MD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Igor Wolfgang Blau, MD PhD

Blood (2014) 124 (21): 3357.

https://doi.org/10.1182/blood.V124.21.3357.3357

Published: 2014

Journal Articles

Achieving Early Remission By Induction Therapy Predicts a Favorable Outcome in Patients with Acute Myeloid Leukemia and an Intermediate Risk Karyotype Undergoing Allogeneic Stem Cell Transplantation in First Complete Remission

Philipp G. Hemmati, MD, Theis H. Terwey, MD, Il-Kang Na, MD, Philipp le Coutre, MD, Christian F. Jehn, MD, Lam G. Vuong, PhD, Bernd Dörken, MD, Renate Arnold, MD

Blood (2014) 124 (21): 2569.

https://doi.org/10.1182/blood.V124.21.2569.2569

Published: 2014

Journal Articles

MSI2 and TGFβR1 Expression Levels in CML Patients and Hematopoietic Cell Lines

Jaspal S Kaeda, PhD, Simone Bonecker, Iris von Wunsch-Rolshoven, Frauke Ringel, PhD, Michaela Schwarz, Bernd Dörken, MD, Ilana Zalcberg, Philipp le Coutre, MD

Blood (2014) 124 (21): 4533.

https://doi.org/10.1182/blood.V124.21.4533.4533

Published: 2014

Journal Articles

Elevated ROS Levels in Response to CD20-Targeting Enhance Senescence Entry after Immunochemotherapy in Human B-Cell Lymphoma

J. Henry M. Däbritz, MD, Yong Yu, Maja Milanovic, PhD, Jan R. Dörr, Andreas M. Kaufmann, MD, Mathias T. Rosenfeldt, MD, Bernd Dörken, MD PhD, Clemens A. Schmitt, MD

Blood (2014) 124 (21): 2240.

https://doi.org/10.1182/blood.V124.21.2240.2240

Published: 2014

Journal Articles

MSI2 and HOXA9 Expression Is Significantly Increased in Patients with Primary Myelofibrosis

Jaspal S Kaeda, PhD, Jackline Ayres-Silva, Leila Amini, BSc, Iris von Wunsch-Rolshoven, Frauke Ringel, PhD, Michaela Schwarz, MD, Bernd Dörken, MD, Ilana Zalcberg, Philipp le Coutre, MD

Blood (2014) 124 (21): 1868.

https://doi.org/10.1182/blood.V124.21.1868.1868

Published: 2014

Journal Articles

Flow Cytometry-Based Maturity Score As a Novel Prognostic Parameter in AML

Anne Flörcken, MD, Schneider Tanja, MD, Anju Singh, MD, Seval Türkmen, MD, Burmeister Thomas, MD PhD, Joannis Anagnostopoulos, MD PhD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Jörg Westermann, MD PhD

Blood (2014) 124 (21): 1006.

https://doi.org/10.1182/blood.V124.21.1006.1006

Published: 2014

NARROW

Clonal Hematopoiesis: Cell of Origin, Lineage Repartition and Dynamic Evolution during Chemotherapy

Prognostic Impact of Distinct Combinations of Molecular Mutations in AML Patients. Results of Two-Center International Cooperation Study

Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

DNMT3A Mutations in AML Patients: Prognostic Impact and Comparative Analysis of Mutations Burden in Diagnostic Samples, after Standard Therapy, and after Allogeneic Stem Cell Transplantation

ΝFΚΒΙΕ Deletions : A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma

Restoring the Lost B-Cell Phenotype Renders Classical Hodgkin's Lymphoma Susceptible to B-Cell-Targeting Therapies

A Novel Bioluminescent Mouse Model for Optimization of Adoptive T Cell Therapy

Efficacy of Adoptive Immunotherapy By Donor Lymphocyte Infusions after Allogeneic Stem Cell Transplantation from Related an Unrelated Donors: A Single Center Retrospective Analysis

Droplet Digital PCR Reliably Detects a Single Copy of BCR-ABL1

Modeling the CNS Tropism of Diffuse Large B-Cell Lymphomas in Vivo

Grouping of Genetic Risk By the European Leukemia Net Classification Predicts Overall Survival and Relapse Incidence in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma

Frequency of a Highly Polymorphic Variant, S36N GFI1 , Is Increased in CML Patients

Multiple Myeloma Cells Induce Mitochondrial Stress Response in Bone Marrow Mesenchymal Stromal Cells

Achieving Early Remission By Induction Therapy Predicts a Favorable Outcome in Patients with Acute Myeloid Leukemia and an Intermediate Risk Karyotype Undergoing Allogeneic Stem Cell Transplantation in First Complete Remission

MSI2 and TGFβR1 Expression Levels in CML Patients and Hematopoietic Cell Lines

Elevated ROS Levels in Response to CD20-Targeting Enhance Senescence Entry after Immunochemotherapy in Human B-Cell Lymphoma

MSI2 and HOXA9 Expression Is Significantly Increased in Patients with Primary Myelofibrosis

Flow Cytometry-Based Maturity Score As a Novel Prognostic Parameter in AML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only